The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
Liposomes, a novel drug delivery system (NDDS), are bilayer vesicular structures used in delivering drugs or genetic material into a cell. The aim of NDDS is to deliver the drug at a rate directed by the needs of the body during the period of treatment. Due to the growing number of COVID-19 patients, especially in the US and the European countries, research institutes are pressurized to accelerate their R&D activities to develop drugs and vaccines for the treatment. Thus, companies in the liposome drug delivery market are capitalizing on this opportunity to increase their research in nanomaterials, such as nanospheres, liposomes, and nanoparticles that are active antiviral agents. Liposome drug delivery is being leveraged with increased in vivo and in vitro drug activities for routine clinical practices.
Lucrative Regions for Liposome Drug Delivery Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Prevalence of Chronic Diseases
Over the past few decades, R&D activities in liposomal drug delivery systems have rapidly increased across the world due to increasing prevalence of chronic disease. Drug delivery is the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Liposomal drug delivery offers various advantages, such as improved pharmacokinetics and pharmacodynamics, enhanced therapeutic efficacy, and decreased toxicity, thereby making these delivery systems ideal for patients suffering from various chronic conditions. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases.
Cancer is one of the leading causes of death among population worldwide. The American Cancer Society (ACS) estimated that ~1,735,350 new cancer cases were diagnosed in 2018. Targeted drug delivery system (TDDS) delivers the drug in a controlled manner at a preselected biosite. Nanotechnology-based delivery systems are making a significant impact on cancer treatment and the polymers play a key role in the development of nanoparticulate carriers for cancer therapy. A few major technological advantages involved in the nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of drug, and many more. The liposomal carriers utilized in nanotechnology drug delivery systems are likely to experience rapid adoption, which, in turn, is propel the market growth.
Product -Based Market Insights
The liposome drug delivery market, based on product, is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin accounted for the largest share by product owing to the high efficacy of the drug exhibited in the treatment of cancer. Moreover, the liposomal doxorubicin is beneficial over its traditional counterpart in terms of toxicity and targeted drug delivery. The drug also exhibits significant recovery among patients suffering with HIV-related Kaposi’s sarcoma and multiple myeloma.
Global Liposome Drug Delivery Market, by Product– 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-Based Market Insights
Based on technology, the liposome drug delivery market is segmented into stealth liposome technology, non-PEGylated liposome technology, DepoFoam liposome technology. The stealth liposome technology segment held the largest share of the market in 2019 and is likely to continue to register the highest CAGR in the market during the forecast period.
Application-Based Market Insights
Based on technology, the liposome drug delivery market is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. The cancer therapy segment held the largest share of the market in 2019 and is likely to continue to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liposome Drug Delivery Market: Strategic Insights
Market Size Value in US$ 3,594.41 Million in 2019 Market Size Value by US$ 6,992.95 Million by 2027 Growth rate CAGR of 8.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liposome Drug Delivery Market: Strategic Insights
| Market Size Value in | US$ 3,594.41 Million in 2019 |
| Market Size Value by | US$ 6,992.95 Million by 2027 |
| Growth rate | CAGR of 8.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Partnerships, agreements, and acquisitions are the most commonly adopted strategies by companies to expand their footprints worldwide and meet the growing demand. The market players most commonly adopt these strategies to expand their geographic presence and product portfolio.
For instance, in April 2019, Ipsen Pharma completed its acquisition of global oncology assets from Merrimack Pharmaceuticals, Cambridge that focuses on ONIVYDE (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
Global Liposome Drug Delivery Market – By Product
- Liposomal Doxorubicin
- Liposomal Paclitaxel
- Liposomal Amphotericin B
- Others
Global Liposome Drug Delivery Market – By Technology
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- DepoFoam Liposome Technology
- Lysolipid Thermally Sensitive Liposome (LTSL) Technology
Global Liposome Drug Delivery Market – By Application
- Fungal Diseases
- Cancer Therapy
- Pain Management
- Viral Vaccines
- Photodynamic Therapy
Liposome Drug Delivery Market – By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
South and Central America
- Brazil
- Argentina
Company Profiles
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Luye Pharma Group
- Ipsen Pharma
- CELSION, Inc.
- Gilead Sciences, Inc.
- Astellas Pharma, Inc.
- Johnson & Johnson Services, Inc.
- Acrotech Biopharma, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Technology ); Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Aregntina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Liposome Drug Delivery Market – By Product
1.3.2 Global Liposome Drug Delivery Market – By Technology
1.3.3 Global Liposome Drug Delivery Market – By Application
1.3.4 Global Liposome Drug Delivery Market – By Geography
2. Liposome Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Liposome Drug Delivery – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
4.2.2 Asia Pacific– PEST Analysis
4.2.3 Middle East & Africa
4.2.4 South and Central America
4.3 Expert Opinion
5. Global Liposome Drug Delivery Market – Industry Dynamics
5.1 Market Drivers
5.1.1 Rising prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Liposome Drug Delivery Market – Global Analysis
6.1 Global Liposome Drug Delivery Market Revenue Forecast And Analysis
6.2 Global Liposome Drug Delivery Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Liposome Drug Delivery Market Analysis – By Product
7.1 Overview
7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
7.3 Liposomal Doxorubicin
7.3.1 Overview
7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liposomal Paclitaxel
7.4.1 Overview
7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Liposomal Amphotericin B
7.5.1 Overview
7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8. Liposome Drug Delivery Market – By Technology
8.1 Overview
8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
8.3.1 Overview
8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
8.4.1 Overview
8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
8.5.1 Overview
8.5.2 DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
8.6.1 Overview
8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Liposome Drug Delivery Market – By Application
9.1 Overview
9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
9.3.1 Overview
9.3.2 Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
9.4.1 Overview
9.4.2 Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
9.5.1 Overview
9.5.2 Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
9.6.1 Overview
9.6.2 Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
9.7.1 Overview
9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Liposome Drug Delivery Market – Geographic Analysis
10.1 North America: Liposome Drug Delivery Market
10.1.1 Overview
10.1.2 North America: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Liposome Drug Delivery Market
10.2.1 Overview
10.2.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Liposome Drug Delivery Market
10.3.1 Overview
10.3.2 Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia Pacific Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.3.7 China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Liposome Drug Delivery Market
10.4.1 Overview
10.4.2 Middle East & Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
10.4.7 Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Liposome Drug Delivery Market
10.5.1 Overview
10.5.2 South and Central America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic On Global Liposome Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Liposome Drug Delivery Market –Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Liposome Drug Delivery Market –Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Novartis AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Luye Pharma Group
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Services, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ipsen Pharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Gilead Sciences, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Celsion, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Astellas Pharma Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Acrotech Biopharma LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Pacira BioSciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by major pharmaceutical companies
Table 2. North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 7. US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 16. Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 19. Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 21. United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 22. United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 23. France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 24. France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 25. France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 31. Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia Pacific Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 35. China Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 36. China Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 37. China Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 40. Japan Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 41. India Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 42. India Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 43. India Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 46. South Korea Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 49. Australia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East & Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East & Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 52. Middle East & Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 55. Saudi Arabia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 58. UAE Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 61. South Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 64. South and Central America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 67. Brazil Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 70. Argentina Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 71. Recent Organic Growth Strategies in the Liposome Drug Delivery Market
Table 72. Recent Inorganic Growth Strategies In The Liposome Drug Delivery Market
Table 73. Glossary of Terms, Liposome Drug Delivery Market
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Market Segmentation
Figure 2. Liposome Drug Delivery Segmentation, By Region
Figure 3. Global Liposome Drug Delivery Market Overview
Figure 4. The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Liposome Drug Delivery Market, By Geography (US$ Million)
Figure 7. Global Liposome Drug Delivery Market, Industry Landscape
Figure 8. Global Liposome Drug Delivery Market- Leading Country Markets (US$ Million)
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Global Liposome Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027
Figure 15. Global Liposome Drug Delivery Market – By Geography Forecast and Analysis – 2019- 2027
Figure 16. Market Positioning Of Key Players In Global Liposome Drug Delivery Market
Figure 17. Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
Figure 18. Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
Figure 23. Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
Figure 28. Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 36. US: Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 40. Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 41. Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 42. Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 48. Asia Pacific Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 49. Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 50. China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East & Africa: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 56. Middle East & Africa Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
Figure 58. Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Impact of COVID-19 Pandemic In North American Country Markets
Figure 67. Impact of COVID-19 Pandemic In European Country Markets
Figure 68. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 69. Impact Of COVID-19 Pandemic In Rest of the World Market
The List of Companies - Liposome Drug Delivery Market
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Luye Pharma Group
- Ipsen Pharma
- CELSION, Inc.
- Gilead Sciences, Inc.
- Astellas Pharma, Inc.
- Johnson & Johnson Services, Inc.
- Acrotech Biopharma, Inc.
- Pacira Biosciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Liposome Drug Delivery Market
Apr 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2020
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)